Skip to main content
Clinical Trials/NL-OMON55376
NL-OMON55376
Recruiting
Phase 3

Improving the quality of life of patients with breast cancer-related lymphedema by lymphaticovenous anastomosis (LVA): A randomized controlled trial - LYMPH-trial

Medisch Universitair Ziekenhuis Maastricht0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \- Women over 18 years old
  • \- Treated for early stage breast cancer and who underwent a sentinel lymph node
  • biopsy, axillary lymph node dissection or axillary radiotherapy
  • \- Early stage lymphedema of the arm (ISL classification stage I/IIa; pitting
  • edema without fibrosis) with viable lymphatic vessels as determined by
  • indocyanin green (ICG\-) lymphography
  • \- Already received at least three months of complex decongestive therapy
  • (currently in the maintenance phase) prior to inclusion
  • \- Primary breast cancer
  • \- Unilateral lymphedema

Exclusion Criteria

  • \- Male sex
  • \- Late stage lymphedema of the arm (ISL classification IIb/III lymphedema) with
  • evident fat deposition and/or fibrosis
  • \- History of earlier lymph reconstruction efforts
  • \- Recurrent breast cancer
  • \- Distant breast cancer metastases
  • \- Bilateral lymphedema
  • \- Primary congenital lymphedema
  • \- Non\-viable lymphatic system as determined by ICG lymphography

Outcomes

Primary Outcomes

Not specified

Similar Trials